Market Overview:
The global veterinary biologics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for animal-derived products, rising awareness about animal health and hygiene, and growing concerns about zoonotic diseases. The livestock segment is expected to account for the majority of the market share during the forecast period. North America is expected to dominate the global veterinary biologics market in terms of revenue due to high adoption rates of advanced technologies and rising demand for meat and dairy products.
Product Definition:
Veterinary biologics are products that contain a virus, bacteria, or other organism used to prevent, control and/or treat diseases in animals. They can be composed of living or dead organisms, cells and tissues. Veterinary biologic products are important for protecting animal health and preventing the spread of disease.
Vaccines:
Vaccines are biological products which act as immunomodulators. They stimulate the body's immune system to fight against foreign substances, mainly harmful bacteria and viruses. The most commonly used vaccine is the flu (flu vaccination), but there are also vaccines for diseases such as polio, rotavirus, smallpox, etc.
Monoclonal Antibodies:
Monoclonal antibodies are antibody molecules, which are produced by the body's immune system to fight against specific harmful substances. In veterinary biologics, monoclonal antibodies can be used for treating diseases that affect animals. Monoclonal Antibodies in Veterinary Biologics market is expected to grow at a lucrative rate during the forecast period due to increasing R&D activities and rising demand for effective treatment of various animal diseases.
Application Insights:
The other application segment includes companion animals, food & feed, and human health. The demand for the other applications is expected to witness a CAGR of XX% from 2018 to 2030 owing to the rising awareness among pet owners regarding chronic diseases in their pets and increasing incidences of cancer in animals worldwide.
Vaccines are one of the most effective ways of preventing disease outbreak in livestock as they protect against multiple diseases at once. Moreover, growing demand for vaccines developed specifically for dogs and cats is expected to boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. North America has a well-established healthcare infrastructure, which makes it an attractive regional market for biologics manufacturers. Moreover, increasing investments in R&D and rising awareness about animal health are some of the factors that can be attributed to this dominance of the region.
Asia Pacific is estimated to be one of the fastest growing regions over the forecast period owing to rapid economic development coupled with increased spending on veterinary healthcare by consumers and governments across countries such as China, India, South Korea & Japan among others). This factor is anticipated to drive demand for veterinary biologics in this region over next eight years.
Growth Factors:
- Increasing demand for animal-derived protein in the human diet is driving the growth of the veterinary biologics market.
- Rising awareness about preventive healthcare and growing pet ownership are also propelling the growth of this market.
- The increasing incidence of zoonotic diseases is fueling demand for veterinary biologics products as a means to prevent their spread.
- Growing investments by key players in research and development activities are resulting in innovations and new product launches, which is aiding the growth of this market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Veterinary Biologics Market Research Report
By Type
Vaccines, Monoclonal Antibodies
By Application
Llivestock, Equine, Other
By Companies
Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco/Eli Lilly, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken, FATRO, Vaksindo, Bio-Labs, Avimex Animal
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Veterinary Biologics Market Report Segments:
The global Veterinary Biologics market is segmented on the basis of:
Types
Vaccines, Monoclonal Antibodies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Llivestock, Equine, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco/Eli Lilly
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal
Highlights of The Veterinary Biologics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vaccines
- Monoclonal Antibodies
- By Application:
- Llivestock
- Equine
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veterinary Biologics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veterinary biologics are products derived from living organisms, such as proteins or vaccines. These products are used to treat animals and protect them from disease.
Some of the major companies in the veterinary biologics market are Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco/Eli Lilly, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken, FATRO, Vaksindo, Bio-Labs, Avimex Animal.
The veterinary biologics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Veterinary Biologics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Veterinary Biologics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Veterinary Biologics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Veterinary Biologics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Veterinary Biologics Market Size & Forecast, 2020-2028
4.5.1 Veterinary Biologics Market Size and Y-o-Y Growth
4.5.2 Veterinary Biologics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Vaccines
5.2.2 Monoclonal Antibodies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Llivestock
6.2.2 Equine
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Veterinary Biologics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Veterinary Biologics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Vaccines
9.6.2 Monoclonal Antibodies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Llivestock
9.10.2 Equine
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Vaccines
10.6.2 Monoclonal Antibodies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Llivestock
10.10.2 Equine
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Vaccines
11.6.2 Monoclonal Antibodies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Llivestock
11.10.2 Equine
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Vaccines
12.6.2 Monoclonal Antibodies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Llivestock
12.10.2 Equine
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Vaccines
13.6.2 Monoclonal Antibodies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Llivestock
13.10.2 Equine
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Veterinary Biologics Market: Competitive Dashboard
14.2 Global Veterinary Biologics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Zoetis
14.3.3 Boehringer Ingelheim
14.3.4 Ceva
14.3.5 CAHIC
14.3.6 HVRI
14.3.7 Ringpu Biology
14.3.8 Yebio
14.3.9 DHN
14.3.10 WINSUN
14.3.11 Elanco/Eli Lilly
14.3.12 Virbac
14.3.13 Jinyu Bio-Technology
14.3.14 ChengDu Tecbond
14.3.15 CAVAC
14.3.16 Kyoto Biken
14.3.17 FATRO
14.3.18 Vaksindo
14.3.19 Bio-Labs
14.3.20 Avimex Animal
